Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis

Clinical trial NCT04002934 · COMPLETED

Trial details

NCT number

NCT04002934

Sponsor

Riley Bove, MD

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2019-09-10

Primary completion

2025-05-13

Enrollment

63

View on ClinicalTrials.gov